Artificial Intelligence (AI)-Enhanced Remote Neonatal Monitoring Global Market Report 2025

The artificial intelligence (AI)-enhanced remote neonatal monitoring market size has grown rapidly in recent years. It will grow from $1.07 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 19%. The growth during the historic period can be attributed to increasing awareness of neonatal mortality, rising adoption of telehealth solutions, higher government funding for infant health programs, expansion of neonatal intensive care units, and the growing prevalence of preterm births.

The artificial intelligence (AI)-enhanced remote neonatal monitoring market size is expected to see rapid growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 18.7%. The growth during the forecast period can be attributed to the increasing demand for remote monitoring solutions, rising focus on personalized neonatal care, expansion of healthcare digitalization initiatives, growth in hospital-homecare integration programs, and increasing adoption of artificial intelligence-based diagnostics. Key trends in the forecast period include advancements in remote sensor technology, innovations in AI-driven predictive analytics, development of wireless neonatal monitoring devices, progress in real-time health data analytics, and advancements in secure cloud-based data sharing.

The increasing incidence of preterm births is expected to drive the growth of the artificial intelligence-enhanced remote neonatal monitoring market during the forecast period. Preterm birth refers to infants born before 37 weeks of gestation, often requiring specialized medical care due to underdeveloped organs and higher health risks. The rise in preterm births is mainly attributed to more women giving birth at an older age, which increases the likelihood of pregnancy complications and premature delivery. Artificial intelligence-enhanced remote neonatal monitoring assists in managing preterm births by continuously analyzing vital signs to detect early signs of complications, enabling timely intervention and safer post-discharge care. For example, in March 2025, according to a report from the Centers for Disease Control and Prevention, a government agency in the United States, the preterm birth rate rose to 10.41 percent in 2023 from 10.38 percent in 2022. Therefore, the increasing incidence of preterm births is fueling the growth of the artificial intelligence-enhanced remote neonatal monitoring market.

Major companies in the artificial intelligence-enhanced remote neonatal monitoring market are focusing on developing advanced solutions such as AI-driven neonatal and pediatric care monitoring platforms to improve early detection of health complications, enhance clinical decision-making, and enable continuous real-time monitoring of newborns. These platforms use artificial intelligence to track and analyze the health data of newborns and children, identify irregularities, and provide actionable insights for timely medical intervention. For example, in April 2025, AngelEye Health, a company based in the United States specializing in neonatal and pediatric family engagement technology, launched AIVision, an innovative platform that integrates artificial intelligence and computer vision into neonatal intensive care units and pediatric units. The platform transforms bedside cameras into intelligent clinical tools that provide proactive, data-driven insights to healthcare teams. Key features include AI-based motion analysis for early detection of neuromotor risks, video EEG synchronization, respiratory monitoring for early distress detection, AI-assisted pain and sedation evaluation, and event recording for clinical review and training.

In September 2024, Samsung Medison, a South Korea-based provider of diagnostic ultrasound and medical imaging solutions, acquired Sonio SAS for approximately 92.4 million dollars. The acquisition aims to strengthen Samsung Medison’s prenatal care portfolio by integrating Sonio’s AI-assisted ultrasound reporting and workflow technologies into its diagnostic systems, improving clinical precision and operational efficiency in maternal healthcare. Sonio SAS, based in France, develops artificial intelligence-powered ultrasound software designed to support clinicians in evaluating and documenting obstetric and gynecological ultrasound examinations, including applications for AI-enhanced remote neonatal monitoring.

Major players in the artificial intelligence (ai)-enhanced remote neonatal monitoring market are Philips Healthcare, GE HealthCare Technologies Inc., Mount Sinai Health System Inc., Mindray Medical International Limited, Drägerwerk AG & Co. KGaA, Hill-Rom Company Inc., Masimo Corporation, Sheba Medical Center, Natus Medical Incorporated, Spacelabs Healthcare Inc., Aver Information Inc., Owlet Inc., Nanit Inc., AngelEye Health Inc., Raybaby Inc., Zoundream Inc., Sempulse Inc., Kriba Inc., Luscii B.V., and Bloomlife Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced remote neonatal monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-enhanced remote neonatal monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-enhanced remote neonatal monitoring market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced remote neonatal monitoring market statistics, including artificial intelligence (AI)-enhanced remote neonatal monitoring industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced remote neonatal monitoring market share, detailed artificial intelligence (AI)-enhanced remote neonatal monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced remote neonatal monitoring industry. This artificial intelligence (AI)-enhanced remote neonatal monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence-enhanced remote neonatal monitoring refers to an advanced system that utilizes AI algorithms to continuously analyze and interpret the vital signs and physiological data of newborns, particularly those who are premature or at high risk, outside conventional hospital environments. It supports predictive analysis and early identification of potential health concerns, enabling timely and informed monitoring of neonatal health.

The primary components of artificial intelligence-enhanced remote neonatal monitoring include hardware, software, and services. Hardware consists of wearable sensors, biosensors, and wireless modules used to continuously monitor the vital signs of newborns. The system covers various types of monitoring, including vital signs monitoring, respiratory monitoring, cardiac monitoring, and others, and is deployed through cloud-based or on-premises systems. Major end users include hospitals, neonatal intensive care units, homecare settings, clinics, and other healthcare facilities.

The countries covered in the artificial intelligence (AI)-enhanced remote neonatal monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced remote neonatal monitoring market consists of revenues earned by entities by providing services such as continuous vital signs monitoring, predictive health analytics, remote data transmission, personalized care recommendations, and trend analysis and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced remote neonatal monitoring market also includes sales of smart wearables for neonates, nutrition monitors, and neonatal imaging systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.